SANUWAVE Health, Inc.
SNWV
$18.61
-$0.24-1.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.98% | 40.89% | 57.43% | 61.50% | 59.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.98% | 40.89% | 57.43% | 61.50% | 59.99% |
| Cost of Revenue | 24.72% | 12.78% | 23.53% | 33.05% | 33.95% |
| Gross Profit | 38.37% | 51.37% | 70.89% | 72.77% | 70.94% |
| SG&A Expenses | 39.25% | 58.31% | 54.84% | 42.11% | 41.77% |
| Depreciation & Amortization | 11.53% | 6.87% | 7.45% | 7.25% | 4.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.85% | 41.91% | 42.56% | 37.64% | 37.50% |
| Operating Income | 28.51% | 34.29% | 297.86% | 1,412.60% | 813.91% |
| Income Before Tax | 136.00% | -2,167.01% | -1,058.40% | -98.27% | -28.11% |
| Income Tax Expenses | 218.52% | 575.00% | 575.00% | 575.00% | 575.00% |
| Earnings from Continuing Operations | 135.71% | -2,150.64% | -1,057.84% | -98.38% | -28.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 135.71% | -2,150.64% | -1,057.84% | -98.38% | -28.19% |
| EBIT | 28.51% | 34.29% | 297.86% | 1,412.60% | 813.91% |
| EBITDA | 27.67% | 29.10% | 178.10% | 421.25% | 848.06% |
| EPS Basic | 118.15% | -587.61% | -168.81% | 32.21% | 55.60% |
| Normalized Basic EPS | 109.13% | -38.68% | -87.10% | 10.80% | 43.43% |
| EPS Diluted | 97.81% | -1,810.99% | -148.76% | 29.05% | 53.75% |
| Normalized Diluted EPS | 108.35% | -36.69% | -85.05% | 10.21% | 43.09% |
| Average Basic Shares Outstanding | 91.89% | 174.15% | 146.81% | 132.25% | 110.85% |
| Average Diluted Shares Outstanding | 93.78% | 171.66% | 140.71% | 137.70% | 117.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |